Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its price target lowered by equities research analysts at Royal Bank Of Canada from $140.00 to $130.00 in a report released on Tuesday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 45.07% [...]
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $130.00 at Royal Bank Of Canada
